A meta-analysis suggests that delaying chemotherapy in patients with asymptomatic, advanced cancer does not worsen overall survival.
Atezolizumab, given with or without radiotherapy, has demonstrated some activity in a subset of patients with penile cancer.
Starting treatment for advanced NSCLC before receiving genomic test results compromises patient outcomes, a study suggests.
After 3 or 4 doses, mRNA-based COVID-19 vaccines are similarly effective in patients with cancer and the general population, a study suggests.
Phase 3 trial results support atezolizumab as a potential first-line treatment option for patients with advanced non-small cell lung cancer.
Patients aged 65 years or older are underrepresented in clinical trials supporting cancer drug approvals, a study suggests.
Researchers say they have identified an unintended effect of Medicare’s 340B Drug Pricing Program; increases in spending for outpatient cancer treatments among patients with commercial insurance.
Researchers looked at the use of 6 biosimilars across 38 oncology practices and found that biosimilar use increased from 2019 to 2021.
Pembrolizumab plus ICE chemotherapy appears effective as second-line treatment in patients with transplant-eligible Hodgkin lymphoma.
Low-dose tamoxifen reduces the risk of breast cancer among patients with intraepithelial neoplasia for several years, data suggest.
